News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011